Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling
Abstract Antibodies with lambda light chains (λ-antibodies) are generally considered to be less developable than those with kappa light chains (κ-antibodies). Though this hypothesis has not been formally established, it has led to substantial systematic biases in drug discovery pipelines and thus co...
Main Authors: | Matthew I. J. Raybould, Oliver M. Turnbull, Annabel Suter, Bora Guloglu, Charlotte M. Deane |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-023-05744-8 |
Similar Items
-
Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling
by: Raybould, MIJ, et al.
Published: (2024) -
Looking for therapeutic antibodies in next-generation sequencing repositories
by: Konrad Krawczyk, et al.
Published: (2019-10-01) -
A comparison of the binding sites of antibodies and single-domain antibodies
by: Gemma L. Gordon, et al.
Published: (2023-07-01) -
Looking for therapeutic antibodies in next-generation sequencing repositories
by: Krawczyk, K, et al.
Published: (2019) -
Five computational developability guidelines for therapeutic antibody profiling
by: Raybould, MIJ, et al.
Published: (2019)